Brevan Howard Capital Management LP Innoviva, Inc. Transaction History
Brevan Howard Capital Management LP
- $13.9 Billion
- Q4 2024
A detailed history of Brevan Howard Capital Management LP transactions in Innoviva, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 16,198 shares of INVA stock, worth $292,859. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,198Holding current value
$292,859% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding INVA
# of Institutions
243Shares Held
77.7MCall Options Held
52.8KPut Options Held
800-
Black Rock Inc. New York, NY9.63MShares$174 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT7.28MShares$132 Million39.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.31MShares$114 Million0.0% of portfolio
-
Putnam Investments LLC Boston, MA6.27MShares$113 Million0.14% of portfolio
-
Dimensional Fund Advisors LP Austin, TX4.92MShares$88.9 Million0.02% of portfolio
About Innoviva, Inc.
- Ticker INVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,706,000
- Market Cap $1.26B
- Description
- Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...